AntineoplasticsGrade 4 skin rash and pneumonitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2028卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67737-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：58 / 58

相关论文

共 50 条

[1] LenalidomideCytopenia and skin rash: 4 case reports
Reactions Weekly, 2015, 1562 (1) : 121 - 121
[2] Ipilimumab/nivolumabSplenic rupture, rash and pneumonitis: 2 case reports
Reactions Weekly, 2019, 1751 (1) : 219 - 219
[3] TacrolimusHeadache and skin rash: 2 case reports
Reactions Weekly, 2017, 1677 (1) : 248 - 248
[4] VemurafenibWeakness and skin rash: 2 case reports
Reactions Weekly, 2018, 1733 (1) : 324 - 324
[5] VemurafenibWeakness and skin rash: 2 case reports
Reactions Weekly, 2016, 1621 (1) : 249 - 249
[6] MercaptopurinePancreatitis and skin rash: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 241 - 241
[7] EtanerceptAutoimmune skin rash: 2 case reports
Reactions Weekly, 1999, 779 (1) : 9 - 9
[8] PembrolizumabAnorexia, pneumonitis and rash: 3 case reports
Reactions Weekly, 2024, 2027 (1) : 418 - 418
[9] AntineoplasticsGrade 3 pneumonitis: case report
Reactions Weekly, 2023, 1952 (1) : 70 - 70
[10] OmalizumabGeneralised skin rash and rash at injection site: 2 case reports
Reactions Weekly, 2019, 1737 (1) : 226 - 226

← 1 2 3 4 5 →